These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18161540)

  • 21. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
    Jacq F; Foulldrin G; Savouré A; Anselme F; Baguelin-Pinaud A; Cribier A; Thibaut F
    Gen Hosp Psychiatry; 2009; 31(3):266-73. PubMed ID: 19410106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance and survival of transvenous defibrillation leads: need for a European data registry.
    Goette A; Cantu F; van Erven L; Geelen P; Halimi F; Merino JL; Morgan JM;
    Europace; 2009 Jan; 11(1):31-4. PubMed ID: 19004838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
    Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA
    J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.
    Biffi M; Ziacchi M; Bertini M; Sangiorgi D; Corsini D; Martignani C; Diemberger I; Boriani G
    Europace; 2008 Nov; 10(11):1288-95. PubMed ID: 18772164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technical and practical aspects of remote monitoring of implantable cardioverter-defibrillator patients in Poland - preliminary results.
    Przybylski A; Zakrzewska-Koperska J; Maciag A; Derejko P; Orczykowski M; Szumowski L; Walczak F
    Kardiol Pol; 2009 May; 67(5):505-11. PubMed ID: 19521935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in anxiety and concerns about the cardioverter defibrillator.
    Spindler H; Johansen JB; Andersen K; Mortensen P; Pedersen SS
    Pacing Clin Electrophysiol; 2009 May; 32(5):614-21. PubMed ID: 19422582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
    Tung R; Zimetbaum P; Josephson ME
    J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America.
    Muratore CA; Batista Sa LA; Chiale PA; Eloy R; Tentori MC; Escudero J; Lima AM; Medina LE; Garillo R; Maloney J
    Europace; 2009 Feb; 11(2):164-8. PubMed ID: 19056745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clustering of device-related concerns and type D personality predicts increased distress in ICD patients independent of shocks.
    Pedersen SS; Theuns DA; Erdman RA; Jordaens L
    Pacing Clin Electrophysiol; 2008 Jan; 31(1):20-7. PubMed ID: 18181906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial.
    Schwab JO; Gasparini M; Lunati M; Proclemer A; Kaup B; Santi E; Ligorio G; Klersy C; DE Sousa J; Okreglicki A; Arenal A; Wijffels M; Lemke B
    J Cardiovasc Electrophysiol; 2009 Jun; 20(6):663-6. PubMed ID: 19175450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of 57,148 transmissions by remote monitoring of implantable cardioverter defibrillators.
    Theuns DA; Rivero-Ayerza M; Knops P; Res JC; Jordaens L
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S63-5. PubMed ID: 19250114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator.
    Serizawa N; Yumino D; Kajimoto K; Tagawa Y; Takagi A; Shoda M; Kasanuki H; Hagiwara N
    Am J Cardiol; 2008 Oct; 102(8):1064-8. PubMed ID: 18929710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with implantable cardioverter-defibrillator therapy in grown-ups with congenital heart disease.
    Tomaske M; Bauersfeld U
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S35-7. PubMed ID: 18226033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable cardioverter defibrillators and their role in heart failure progression.
    Cevik C; Perez-Verdia A; Nugent K
    Europace; 2009 Jun; 11(6):710-5. PubMed ID: 19357142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of body weight with total mortality and with ICD shocks among survivors of ventricular fibrillation in out-of-hospital cardiac arrest.
    Bunch TJ; White RD; Lopez-Jimenez F; Thomas RJ
    Resuscitation; 2008 Jun; 77(3):351-5. PubMed ID: 18308453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automatic R-wave and impedance testing with the modern patient alert system to reduce inappropriate implantable cardioverter defibrillator shocks due to lead fracture.
    Chinushi M; Hosaka Y; Ikarashi N; Iijima K; Furushima H; Aizawa Y
    Europace; 2008 Jun; 10(6):738-40. PubMed ID: 18390874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.